PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
University of Alabama at Birmingham, Birmingham, Alabama Australia
Royal North Shore Hospital, St Leonards, New South Wales Peter MacCallum Cancer Centre, Melbourne, Victoria South Korea
Asan Medical Center, Seoul Severance Hospital, Yonsei University Health System, Sinchon-dong Last updated December 2025